1. Home
  2. CYCN vs MEGL Comparison

CYCN vs MEGL Comparison

Compare CYCN & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCN
  • MEGL
  • Stock Information
  • Founded
  • CYCN 2018
  • MEGL 2016
  • Country
  • CYCN United States
  • MEGL Hong Kong
  • Employees
  • CYCN N/A
  • MEGL N/A
  • Industry
  • CYCN Biotechnology: Pharmaceutical Preparations
  • MEGL Finance: Consumer Services
  • Sector
  • CYCN Health Care
  • MEGL Finance
  • Exchange
  • CYCN Nasdaq
  • MEGL Nasdaq
  • Market Cap
  • CYCN 8.4M
  • MEGL 9.0M
  • IPO Year
  • CYCN N/A
  • MEGL 2022
  • Fundamental
  • Price
  • CYCN $4.21
  • MEGL $0.52
  • Analyst Decision
  • CYCN
  • MEGL
  • Analyst Count
  • CYCN 0
  • MEGL 0
  • Target Price
  • CYCN N/A
  • MEGL N/A
  • AVG Volume (30 Days)
  • CYCN 5.8M
  • MEGL 248.0K
  • Earning Date
  • CYCN 03-04-2025
  • MEGL 10-30-2024
  • Dividend Yield
  • CYCN N/A
  • MEGL N/A
  • EPS Growth
  • CYCN N/A
  • MEGL N/A
  • EPS
  • CYCN N/A
  • MEGL N/A
  • Revenue
  • CYCN $194,000.00
  • MEGL $1,976,138.00
  • Revenue This Year
  • CYCN N/A
  • MEGL N/A
  • Revenue Next Year
  • CYCN N/A
  • MEGL N/A
  • P/E Ratio
  • CYCN N/A
  • MEGL N/A
  • Revenue Growth
  • CYCN N/A
  • MEGL 67.75
  • 52 Week Low
  • CYCN $1.27
  • MEGL $0.41
  • 52 Week High
  • CYCN $9.47
  • MEGL $1.38
  • Technical
  • Relative Strength Index (RSI)
  • CYCN 58.42
  • MEGL 42.45
  • Support Level
  • CYCN $2.81
  • MEGL $0.49
  • Resistance Level
  • CYCN $6.25
  • MEGL $0.54
  • Average True Range (ATR)
  • CYCN 0.67
  • MEGL 0.05
  • MACD
  • CYCN 0.17
  • MEGL -0.01
  • Stochastic Oscillator
  • CYCN 48.35
  • MEGL 24.26

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

About MEGL Magic Empire Global Limited

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

Share on Social Networks: